| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate...
On October 18, 2025, Bruce Thornton was terminated as an employee and Executive Vice President and Chief Operating Officer of t...
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001367083/000168316825007265/sonoma_8k.htm
Healthcare stocks SNOA, EVOK, KALA, DNA, & SNGX soar with massive momentum gains, signaling breakout potential in biotech &...